Disseminated Saccharomyces cerevisiae infection in advanced HIV: a literature review

IF 8.5 1区 医学 Q1 INFECTIOUS DISEASES Clinical Microbiology and Infection Pub Date : 2025-02-13 DOI:10.1016/j.cmi.2025.02.009
Lucy X. Li , Amita Gupta , Matthew M. Hamill , Sean X. Zhang , Yukari C. Manabe
{"title":"Disseminated Saccharomyces cerevisiae infection in advanced HIV: a literature review","authors":"Lucy X. Li ,&nbsp;Amita Gupta ,&nbsp;Matthew M. Hamill ,&nbsp;Sean X. Zhang ,&nbsp;Yukari C. Manabe","doi":"10.1016/j.cmi.2025.02.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><em>Saccharomyces cerevisiae</em> is a common environmental fungus and an uncommon, but increasingly recognized, cause of invasive fungal infection. The clinical manifestations of this infection can often be mistaken for histoplasmosis, a major cause of mortality in patients with advanced HIV.</div></div><div><h3>Objectives</h3><div>This study aims to review the current epidemiology, diagnostic approaches, and management strategies for <em>S. cerevisiae</em> infection in patients with HIV.</div></div><div><h3>Sources</h3><div>A literature search was conducted using PubMed from January 1980 and May 2024.</div></div><div><h3>Content</h3><div>This review features a case of <em>S. cerevisiae</em> infection in a patient with HIV to highlight the diagnostic challenges and clinical implications of disseminated infection. A summary of published cases in patients with vs. without HIV is provided alongside a review and discussion of both conventional and novel diagnostic methods. The role of current antifungal therapies in managing <em>S. cerevisiae</em> infections is also examined.</div></div><div><h3>Implications</h3><div>S. <em>cerevisiae</em> is a rare but clinically important opportunistic pathogen in patients with advanced HIV who have epidemiological risk factors. When found in mucocutaneous lesions under the appropriate clinical scenario, <em>S. cerevisiae</em> should not automatically be dismissed as commensal flora.</div></div>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":"31 5","pages":"Pages 773-777"},"PeriodicalIF":8.5000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1198743X25000680","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Saccharomyces cerevisiae is a common environmental fungus and an uncommon, but increasingly recognized, cause of invasive fungal infection. The clinical manifestations of this infection can often be mistaken for histoplasmosis, a major cause of mortality in patients with advanced HIV.

Objectives

This study aims to review the current epidemiology, diagnostic approaches, and management strategies for S. cerevisiae infection in patients with HIV.

Sources

A literature search was conducted using PubMed from January 1980 and May 2024.

Content

This review features a case of S. cerevisiae infection in a patient with HIV to highlight the diagnostic challenges and clinical implications of disseminated infection. A summary of published cases in patients with vs. without HIV is provided alongside a review and discussion of both conventional and novel diagnostic methods. The role of current antifungal therapies in managing S. cerevisiae infections is also examined.

Implications

S. cerevisiae is a rare but clinically important opportunistic pathogen in patients with advanced HIV who have epidemiological risk factors. When found in mucocutaneous lesions under the appropriate clinical scenario, S. cerevisiae should not automatically be dismissed as commensal flora.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
晚期HIV患者弥散性酿酒酵母感染:文献综述。
背景:酿酒酵母是一种常见的环境真菌,是一种不常见但越来越被认识到的侵袭性真菌感染的原因。这种感染的临床表现常常被误认为是组织胞浆菌病,这是晚期HIV患者死亡的主要原因。目的:综述HIV患者酿酒葡萄球菌感染的流行病学现状、诊断方法和治疗策略。资料来源:1980年1月至2024年5月在PubMed进行文献检索。内容:本综述以一例酿酒葡萄球菌感染的HIV患者为特征,强调了弥散性感染的诊断挑战和临床意义。对已发表的艾滋病患者与非艾滋病患者的病例进行了总结,同时对传统和新型诊断方法进行了回顾和讨论。目前的抗真菌治疗在管理酿酒葡萄球菌感染的作用也进行了检查。意义:酿酒葡萄球菌是具有流行病学危险因素的晚期HIV患者中一种罕见但临床上重要的机会性病原体。当在适当的临床情况下在皮肤粘膜病变中发现酿酒葡萄球菌时,不应自动将其视为共生菌群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
25.30
自引率
2.10%
发文量
441
审稿时长
2-4 weeks
期刊介绍: Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.
期刊最新文献
An unwanted souvenir from Southern Europe: visceral leishmaniasis. End-of-life antibiotic stewardship: perspectives from the ESCMID Study Groups for Antimicrobial Stewardship and Infections in the Elderly. Addressing vaccine hesitancy in health care workers promotes public vaccination. Does it still make sense to talk about carbapenem-sparing? Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an anti-staphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: pre-planned analysis from CAMERA2.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1